Professor in the Departments of Behavioral Science and Psychiatry, and Bell Alcohol and Addictions Chair
University of Kentucky, USA
Biography
Michelle Lofwall MD is a Professor in the Departments of Behavioral Science and Psychiatry and the Bell Alcohol and Addictions Endowed Chair at the University of Kentucky. She completed residency and a behavioral pharmacology fellowship at Johns Hopkins University. Currently, she is the medical director of the First Bridge Clinic that provides comprehensive low barrier opioid use disorder (OUD) treatment. Her passion is in improving the care of patients with addiction, and her research has included evaluation of novel treatments for opioid use disorder (e.g., buprenorphine implants and depot injections), improving care delivery of complex patients with OUD, and best practices for linking and retaining persons in care for OUD treatment. She was a treatment team leader for Kentucky’s National Institute of Health-funded Helping End Addiction Long-term Communities Study (HCS) and spearheaded the development of the HCS national policy workgroup. She was elected as a Distinguished Fellow of American Society of Addiction Medicine and the American Psychiatric Association. She has received numerous teaching and mentoring awards, the Nyswander/Dole (Marie) Award from the American Association for the Treatment of Opioid Dependence and was an expert panel member for SAMHSA’s Treatment Improvement Protocol on Medication Treatment for Opioid Use Disorder (TIP 63).